Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

The Effect of Adipose Tissue Mesenchymal Stem Cells and Melatonin in a Rat Model of Renal Ischemia Reperfusion Injury.

Yaşar FK., Çil N., Önder E., Avcı E., Özlülerden Y., Abban Mete G.

Animal Study on Acute Kidney Injury, published in Int J Urol (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Int J Urol (2025)
Country
Australia
Reported sample size
—
Source database
PubMed
PMID
40213879
DOI
10.1111/iju.70054
Citations
1

Abstract (original English)

We aimed to determine the effects of adipose-derived mesenchymal stem cells (AD-MSCs) and melatonin on the kidney in rats with ischemia-reperfusion injury. Sixty male rats were divided into six groups: Control group (C) (n: 10), Sham group (S) (n: 10), Ischemia Reperfusion group (IR) (n: 10), Group that was treated with melatonin intraperitoneally after ischemia reperfusion (IR+M) (n: 10), Group in which AD-MSCs were applied locally after ischemia reperfusion (IR+MSC) (n: 10), and group that after IR, melatonin and AD-MSCs were administered (IR+MSC+M) (n: 10). Five rats from each group were sacrificed on day 3 and five of them on day 14. Blood samples were analyzed for BUN and creatinine. Histological analysis was performed. BUN and creatinine levels were higher in the IR group compared to the groups (p < 0.05). There was a statistically significant decrease in creatinine levels in the IR+MSC+M group on day 14. BUN levels decreased significantly in the M and IR+MSC+M groups (p < 0.05). Losses in the glomerular epithelium and tubule cells, enlargement, and hemorrhage areas in the bowman space were detected in the IR group. The histologic scoring was significantly lower in the IR+MSC+M group on the 14th day (p < 0.05). While Caspase-3 and Bax expression increased in the IR group, it decreased in the treatment group, especially on day 14 (p < 0.05). Bcl-2 expression was negative i

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMelatoninReperfusion InjuryMaleRatsMesenchymal Stem Cell TransplantationDisease Models, AnimalKidneyAdipose TissueMesenchymal Stem Cells

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research